Nifty
Sensex
:
:
12987.00
44259.74
128.60 (1.00%)
431.64 (0.98%)

Pharmaceuticals & Drugs

Rating :
56/99  (View)

BSE: 500259 | NSE: LYKALABS

20.35
0.55 (2.78%)
26-Nov-2020 | 3:52PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  20.70
  •  20.80
  •  19.60
  •  19.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  37000
  •  7.53
  •  24.70
  •  9.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 57.38
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 188.79
  • N/A
  • -2.38

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 19.88%
  • 1.97%
  • 61.65%
  • FII
  • DII
  • Others
  • 3.5%
  • 0.47%
  • 12.53%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -13.98
  • 0.89

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 0.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 52.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.37
  • -1.58
  • -5.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 99.68
  • 150.46
  • 239.28

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
17
14
28%
18
14
23%
15
24
-37%
18
18
2%
Expenses
14
14
-2%
14
15
-10%
15
25
-41%
20
14
44%
EBITDA
3
-1
-
4
-1
-
0
-1
-
-2
4
-
EBIDTM
20%
-5%
22%
-7%
2%
-4%
-11%
22%
Other Income
0
0
3%
0
0
57%
1
1
62%
1
0
94%
Interest
7
2
323%
6
2
282%
6
3
94%
11
1
760%
Depreciation
2
2
6%
2
2
3%
2
1
128%
2
2
16%
PBT
-5
-4
-
-4
-4
-
-13
-2
-
-41
-2
-
Tax
0
0
260%
0
-1
-
1
-9
-
0
0
0
PAT
-6
-4
-
-4
-4
-
-14
8
-
-41
-2
-
PATM
-33%
-29%
-23%
-27%
-92%
32%
-223%
-12%
EPS
-1.99
-1.38
-
-1.42
-1.33
-
-4.86
2.69
-
-14.26
-0.74
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Sep 10
Net Sales
69
61
71
60
110
130
166
119
127
170
147
Net Sales Growth
-2%
-13%
18%
-46%
-16%
-22%
40%
-6%
-25%
15%
 
Cost Of Goods Sold
36
36
39
29
54
70
91
64
67
102
85
Gross Profit
33
26
32
30
56
60
76
55
60
68
62
GP Margin
48%
42%
45%
51%
51%
46%
45%
46%
47%
40%
42%
Total Expenditure
63
65
73
63
87
110
138
110
106
155
123
Power & Fuel Cost
-
3
2
2
2
1
2
3
2
2
2
% Of Sales
-
4%
3%
3%
2%
1%
1%
3%
2%
1%
1%
Employee Cost
-
14
15
17
17
15
17
16
14
21
11
% Of Sales
-
23%
21%
28%
16%
11%
10%
14%
11%
12%
7%
Manufacturing Exp.
-
2
1
1
1
1
2
1
2
4
3
% Of Sales
-
3%
2%
2%
1%
1%
1%
1%
2%
2%
2%
General & Admin Exp.
-
6
6
6
6
7
7
6
6
7
5
% Of Sales
-
9%
8%
10%
5%
5%
4%
5%
5%
4%
3%
Selling & Distn. Exp.
-
3
5
3
0
9
13
11
9
7
9
% Of Sales
-
5%
7%
5%
0%
7%
8%
9%
7%
4%
6%
Miscellaneous Exp.
-
3
4
5
7
7
5
8
6
12
9
% Of Sales
-
4%
6%
9%
6%
6%
3%
7%
5%
7%
6%
EBITDA
6
-4
-2
-4
23
20
29
9
22
15
24
EBITDA Margin
8%
-6%
-3%
-6%
21%
15%
17%
7%
17%
9%
16%
Other Income
3
3
2
2
2
2
2
5
3
4
2
Interest
30
20
7
10
19
16
26
29
21
30
17
Depreciation
8
8
7
11
10
9
11
9
12
9
6
PBT
-63
-29
-14
-22
-4
-4
-5
-23
-8
-20
3
Tax
2
1
-9
-1
-2
0
1
1
0
0
0
Tax Rate
-2%
-1%
59%
5%
19%
-5%
-29%
-31%
0%
0%
-2%
PAT
-65
-61
-6
-17
-6
4
-5
-7
-1
-7
2
PAT before Minority Interest
-64
-63
-6
-19
-7
4
-5
-5
0
-8
3
Minority Interest
1
2
1
2
1
0
0
-1
-1
1
0
PAT Margin
-94%
-99%
-8%
-29%
-5%
3%
-3%
-6%
-1%
-4%
2%
PAT Growth
0%
-991%
68%
-211%
-250%
175%
25%
-828%
90%
-386%
 
EPS
-22.53
-21.09
-1.93
-6.00
-1.93
1.29
-1.72
-2.30
-0.25
-2.40
0.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Sep 10
Shareholder's Funds
-14
43
49
38
45
43
53
67
74
102
Share Capital
29
28
28
22
23
23
23
23
23
23
Total Reserves
-43
14
21
16
22
20
30
44
51
80
Non-Current Liabilities
137
72
5
39
29
37
65
72
74
114
Secured Loans
125
78
4
35
25
29
50
54
56
84
Unsecured Loans
1
1
1
1
0
0
8
14
15
30
Long Term Provisions
4
4
4
4
3
4
4
4
3
0
Current Liabilities
66
85
167
165
163
195
208
147
132
100
Trade Payables
17
23
24
39
42
55
63
43
44
71
Other Current Liabilities
32
43
92
73
57
79
78
44
39
28
Short Term Borrowings
14
16
46
50
60
60
66
59
49
0
Short Term Provisions
2
2
5
3
4
1
1
1
1
0
Total Liabilities
188
203
225
249
240
279
329
289
283
318
Net Block
105
108
116
133
104
122
162
125
127
164
Gross Block
209
203
155
144
200
214
248
195
186
214
Accumulated Depreciation
104
95
39
11
96
92
86
70
59
50
Non Current Assets
152
168
176
186
159
177
211
162
168
178
Capital Work in Progress
28
31
28
24
30
27
22
15
19
8
Non Current Investment
0
0
0
0
0
0
0
6
6
6
Long Term Loans & Adv.
19
29
32
29
24
28
27
17
16
0
Other Non Current Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
36
35
49
63
82
102
118
127
115
135
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
7
7
11
13
11
19
16
18
16
14
Sundry Debtors
8
15
20
29
43
57
68
73
61
90
Cash & Bank
10
2
2
5
6
7
11
5
2
5
Other Current Assets
11
2
2
4
22
19
24
30
36
25
Short Term Loans & Adv.
6
10
13
11
17
15
18
17
31
25
Net Current Assets
-30
-50
-118
-103
-81
-94
-90
-21
-17
35
Total Assets
188
203
225
249
241
279
329
289
283
318

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Sep 10
Cash From Operating Activity
5
27
11
31
12
27
89
11
1
15
PBT
-62
-15
-20
-8
4
-5
-7
-1
-7
2
Adjustment
56
15
21
31
16
32
33
17
24
24
Changes in Working Capital
11
28
10
10
-8
-1
67
-5
-16
-12
Cash after chg. in Working capital
5
27
11
33
12
26
93
11
1
14
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
0
-1
0
-1
0
0
1
0
1
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
1
-5
0
0
0
Cash From Investing Activity
0
-4
-3
-13
17
29
-57
5
12
-6
Net Fixed Assets
-3
-2
-4
13
-5
29
-9
-11
17
-55
Net Investments
0
0
0
0
0
0
-42
0
0
0
Others
3
-2
0
-26
22
0
-5
16
-5
49
Cash from Financing Activity
3
-23
-10
-19
-30
-60
-26
-13
-16
-11
Net Cash Inflow / Outflow
8
-1
-3
0
-1
-4
6
3
-3
-2
Opening Cash & Equivalents
2
2
5
6
7
11
5
2
5
7
Closing Cash & Equivalent
10
2
2
5
6
7
11
5
2
5

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Sep 10
Book Value (Rs.)
-5
15
17
16
17
15
19
26
26
27
ROA
-32%
-3%
-8%
-3%
2%
-2%
-2%
0%
-3%
1%
ROE
-449%
-14%
-46%
-18%
12%
-13%
-11%
1%
-13%
5%
ROCE
-31%
-6%
-7%
7%
12%
12%
12%
11%
13%
12%
Fixed Asset Turnover
0.30
0.40
0.41
0.68
0.65
0.75
0.57
0.70
0.90
0.81
Receivable days
67
91
150
113
136
132
205
183
154
188
Inventory Days
41
47
74
38
41
37
49
47
31
32
Payable days
111
128
181
175
169
159
188
139
136
182
Cash Conversion Cycle
-3
10
42
-24
8
10
66
91
49
38
Total Debt/Equity
-9.85
2.28
2.39
3.60
3.12
4.05
3.97
2.62
2.31
1.92
Interest Cover
-2
-1
-1
1
1
1
1
1
1
1

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.